Literature DB >> 1914756

Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.

J Miholic1, C Orskov, J J Holst, J Kotzerke, H J Meyer.   

Abstract

Postprandial glucagon-like peptide-1 (GLP-1), pancreatic glucagon, and insulin were measured in 27 tumor-free patients 43 months (median) after total gastrectomy and in four controls using a 99technetium-labeled 100-g carbohydrate solid test meal. Emptying of the gastric substitute was measured by scintigraphy. Fourteen patients suffered from early dumping symptoms, and five of them also reported symptoms suggestive of reactive hypoglycemia (late dumping). The median emptying half-time (T1/2) of the gastric substitute was 480 sec. Sigstad's dumping score was 8.5 +/- 1.6 (mean +/- SE) in patients with rapid emptying (T1/2 less than 480 sec), and 3.0 +/- 1.5 in patients with slow emptying of the gastric substitute (P = 0.02). The peak postprandial concentration of GLP-1 was 44 +/- 20 pmol/liter in controls, 172 +/- 50 in patients without reactive hypoglycemia, and 502 +/- 116 in patients whose glucose fell below 3.8 mmol/liter during the second postprandial hour. Plasma GLP-1 concentrations peaked at 15 min, and insulin concentrations at 30 min after the end of the meal. A close correlation between integrated GLP-1 responses and integrated insulin responses (r = 0.68) was observed. Multiple regression revealed that three factors were significantly associated with the integrated glucose concentrations during the second hour (60-120 min): Early (first 30 min) integrated GLP-1 (inverse correlation; P = 0.006), age (P = 0.006), and early integrated pancreatic glucagon (P = 0.005). There was a close (inverse) relationship of T1/2 with early integrated GLP-1 and pancreatic glucagon, but not with insulin. Gel filtration of pooled postprandial plasma of gastrectomized individuals revealed that all glucagon-like immunoreactivity eluted at Kd 0.30 (Kd, coefficient of distribution), the elution position of glicentin. Almost all of the GLP-1 like immunoreactivity eluted at Kd 0.60, the elution position of gut GLP-1. The authors contend that GLP-1-induced insulin release and inhibition of pancreatic glucagon both contribute to the reactive hypoglycemia encountered in some patients following gastric surgery. Rapid emptying seems to be one causative factor for the exaggerated GLP-1 release in these subjects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914756     DOI: 10.1007/bf01296800

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  43 in total

1.  Functional results of different reconstructive procedures after total gastrectomy.

Authors:  M Huguier; J M Lancret; P F Bernard; C Baschet; F Le Henand
Journal:  Br J Surg       Date:  1976-09       Impact factor: 6.939

2.  Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.

Authors:  J J Holst; T I Sørensen; A N Andersen; F Stadil; B Andersen; K B Lauritsen; H C Klein
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

3.  Plasma glucagon and insulin responses to various sugars in gastrectomized and normal subjects.

Authors:  K Shima; K Kuroda; T Matsuyama; S Tarui; M Nishikawa
Journal:  Proc Soc Exp Biol Med       Date:  1972-03

4.  Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

Authors:  S Mojsov; G C Weir; J F Habener
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

5.  Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut.

Authors:  J J Holst; C Orskov; O V Nielsen; T W Schwartz
Journal:  FEBS Lett       Date:  1987-01-26       Impact factor: 4.124

6.  Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.

Authors:  G Schattenmann; R Ebert; R Siewert; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1984-03       Impact factor: 2.423

7.  Plasma enteroglucagon and plasma volume change after gastric surgery.

Authors:  J P Thomson; S R Bloom
Journal:  Clin Sci Mol Med       Date:  1976-08

8.  Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis.

Authors:  O Lawaetz; A M Blackburn; S R Bloom; Y Aritas; D N Ralphs
Journal:  Scand J Gastroenterol       Date:  1983-01       Impact factor: 2.423

9.  Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.

Authors:  C Orskov; J J Holst; S Knuhtsen; F G Baldissera; S S Poulsen; O V Nielsen
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

10.  Glucagon-related peptides in the human gastrointestinal mucosa.

Authors:  F G Baldissera; J J Holst
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

View more
  36 in total

1.  Effect of steroid therapy for late dumping syndrome after total gastrectomy: report of a case.

Authors:  Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Ken-ichi Shiiba; Iwao Sasaki; Kei-ichi Itoi; Hiroo Naito
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

2.  Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus.

Authors:  Woohyung Lee; Sang Hoon Ahn; Jue Hee Lee; Do Joong Park; Hyuk-Joon Lee; Hyung-Ho Kim; Han-Kwang Yang
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

3.  A rehabilitation program for patients with gastroesophageal cancer--a pilot study.

Authors:  Martin Robert Chasen; Ravi Bhargava
Journal:  Support Care Cancer       Date:  2010-02-23       Impact factor: 3.603

4.  Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line.

Authors:  F Reimann; M Maziarz; G Flock; A M Habib; D J Drucker; F M Gribble
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

Review 5.  Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

Authors:  M A Nauck; I Vardarli; C F Deacon; J J Holst; J J Meier
Journal:  Diabetologia       Date:  2010-09-25       Impact factor: 10.122

6.  Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication.

Authors:  J Miholic; M Hoffmann; J J Holst; J Lenglinger; M Mittlböck; H Bergmann; G Stacher
Journal:  Surg Endosc       Date:  2007-01-02       Impact factor: 4.584

7.  Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia.

Authors:  Viney K Mathavan; Maurice Arregui; Chad Davis; Kirpal Singh; Anand Patel; James Meacham
Journal:  Surg Endosc       Date:  2010-03-31       Impact factor: 4.584

Review 8.  Could the mechanisms of bariatric surgery hold the key for novel therapies? report from a Pennington Scientific Symposium.

Authors:  C S Tam; H-R Berthoud; M Bueter; M V Chakravarthy; A Geliebter; A Hajnal; J Holst; L Kaplan; W Pories; H Raybould; R Seeley; A Strader; E Ravussin
Journal:  Obes Rev       Date:  2011-07-06       Impact factor: 9.213

Review 9.  Physiology of incretins in health and disease.

Authors:  Carolyn F Deacon; Bo Ahrén
Journal:  Rev Diabet Stud       Date:  2011-11-10

10.  Increased glucagon-like peptide-1 secretion and postprandial hypoglycemia in children after Nissen fundoplication.

Authors:  Andrew A Palladino; Samir Sayed; Lorraine E Levitt Katz; Paul R Gallagher; Diva D De León
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.